146 related articles for article (PubMed ID: 9358565)
1. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol).
Oussoren C; Storm G
Pharm Res; 1997 Oct; 14(10):1479-84. PubMed ID: 9358565
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection . IV. Fate of liposomes in regional lymph nodes.
Oussoren C; Velinova M; Scherphof G; van der Want JJ; van Rooijen N; Storm G
Biochim Biophys Acta; 1998 Mar; 1370(2):259-72. PubMed ID: 9545576
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose.
Oussoren C; Zuidema J; Crommelin DJ; Storm G
Biochim Biophys Acta; 1997 Sep; 1328(2):261-72. PubMed ID: 9315622
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic targeting of immuno-PEG-liposomes: evaluation of antibody-coupling procedures on lymph node macrophage uptake.
Moghimi M; Moghimi SM
J Drug Target; 2008 Aug; 16(7):586-90. PubMed ID: 18686128
[TBL] [Abstract][Full Text] [Related]
5. Liposomes to target the lymphatics by subcutaneous administration.
Oussoren C; Storm G
Adv Drug Deliv Rev; 2001 Aug; 50(1-2):143-56. PubMed ID: 11489337
[TBL] [Abstract][Full Text] [Related]
6. Role of macrophages in the localisation of liposomes in lymph nodes after subcutaneous administration.
Oussoren C; Storm G
Int J Pharm; 1999 Jun; 183(1):37-41. PubMed ID: 10361151
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s.
Shimada K; Kamps JA; Regts J; Ikeda K; Shiozawa T; Hirota S; Scherphof GL
Biochim Biophys Acta; 1997 Jun; 1326(2):329-41. PubMed ID: 9218563
[TBL] [Abstract][Full Text] [Related]
8. Enhanced lymph node retention of subcutaneously injected IgG1-PEG2000-liposomes through pentameric IgM antibody-mediated vesicular aggregation.
Moghimi SM; Moghimi M
Biochim Biophys Acta; 2008 Jan; 1778(1):51-5. PubMed ID: 17936719
[TBL] [Abstract][Full Text] [Related]
9. The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes.
Moghimi SM
Biomaterials; 2006 Jan; 27(1):136-44. PubMed ID: 16019063
[TBL] [Abstract][Full Text] [Related]
10. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection.
Allen TM; Hansen CB; Guo LS
Biochim Biophys Acta; 1993 Jul; 1150(1):9-16. PubMed ID: 8334142
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an inflammation model.
Corvo ML; Boerman OC; Oyen WJ; Jorge JC; Cruz ME; Crommelin DJ; Storm G
Pharm Res; 2000 May; 17(5):600-6. PubMed ID: 10888313
[TBL] [Abstract][Full Text] [Related]
13. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
[TBL] [Abstract][Full Text] [Related]
14. Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration.
Ye T; Wu Y; Shang L; Deng X; Wang S
Drug Deliv; 2018 Nov; 25(1):1461-1471. PubMed ID: 29902927
[TBL] [Abstract][Full Text] [Related]
15. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.
Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Stewart JS
Clin Cancer Res; 2000 Jun; 6(6):2528-37. PubMed ID: 10873109
[TBL] [Abstract][Full Text] [Related]
16. MPEG-DSPE polymeric micelle for translymphatic chemotherapy of lymph node metastasis.
Li X; Dong Q; Yan Z; Lu W; Feng L; Xie C; Xie Z; Su B; Liu M
Int J Pharm; 2015 Jun; 487(1-2):8-16. PubMed ID: 25841567
[TBL] [Abstract][Full Text] [Related]
17. The effect of RMP-7 and its derivative on transporting Evans blue liposomes into the brain.
Zhang X; Xie Y; Jin Y; Hou X; Ye L; Lou J
Drug Deliv; 2004; 11(5):301-9. PubMed ID: 15742555
[TBL] [Abstract][Full Text] [Related]
18. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake.
Hawley AE; Illum L; Davis SS
Pharm Res; 1997 May; 14(5):657-61. PubMed ID: 9165539
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.
Parker RJ; Hartman KD; Sieber SM
Cancer Res; 1981 Apr; 41(4):1311-7. PubMed ID: 7214320
[TBL] [Abstract][Full Text] [Related]
20. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
